Migraine Disorders  >>  Zecuity (transdermal sumatriptan)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zecuity (transdermal sumatriptan) / Teva
NP101-006, NCT00720018: Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers

Completed
1
4
US
NP101 Sumatriptan Iontophoretic Transdermal Patch
NuPathe Inc.
Migraine Disorders
07/08
07/08
NP101-011, NCT00723983: Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

Completed
1
23
US
Sumatriptan succinate, NP101 Study Patch
NuPathe Inc.
Migraine Disorders
09/09
09/09

Download Options